Skip to main content

Table 2 Characteristics of patients of the 4 nutrition groups categorized based on SGA

From: Exploring the malnutrition status and impact of total parenteral nutrition on the outcome of patients with advanced stage ovarian cancer

 

Nourished (n = 202)

Moderately malnourished (n = 115)

Severely malnourished (n = 98)

P value

Age (years, median, range)

50 (25–75)

54 (25–74)

45 (26–75)

0.2268

Surgical FIGO stage

   

0.0745

Stage 3 (n, %)

175 (86.6%)

98 (85.2%)

75 (76.5%)

 

Stage 4 (n, %)

27 (13.4%)

17 (14.8%)

23 (23.5%)

 

Histology

   

0.7059

Serous (n, %)

166 (82.2%)

89 (77.4%)

75 (76.5%)

 

Endometrioid (n, %)

22 (10.9%)

15 (13.0%)

11 (11.2%)

 

Mixed (n, %)

6 (3.0%)

5 (4.3%)

4 (4.1%)

 

Clear cell (n, %)

5 (2.5%)

4 (3.5%)

2 (2.0%)

 

Other (n, %)

3 (1.5%)

2 (1.7%)

5 (5.1%)

 

Cytoreduction

   

0.0793

Optimal (n, %)

177 (87.6%)

97 (84.3%)

76 (77.6%)

 

Sub-optimal (n, %)

25 (12.4%)

18 (15.7%)

22 (22.4%)

 

Days to flatus (median, range)

7 (4–10)

7 (4–10)

6.5 (4–10)

0.7305

Days of hospitalization (median, range)

12 (5–20)

13 (5–20)

12.5 (5–20)

0.673

Serum albumin (g/L) (median, range)

4.9 (3–6)

3.3 (1–5.9)

2.45 (1–4.8)

< 0.001

BMI at admission (median, range)

27.9 (16.1–40)

22.8 (16.1–39.6)

20.15 (16–29.3)

< 0.001

BMI after surgery (median, range)

25.9 (15.2–35)

23.8 (15.2–30.9)

21.05 (16–26)

< 0.001

NRI at admission (median, range)

100 (97.5–108)

92 (83.5–99.9)

80.15 (75.5–91.4)

< 0.001

PFS (days, median, range)

108 (20–200)

90 (10–179)

67.5 (10–120)

< 0.001

OS (days, median, range)

240.5 (102–396)

227 (100–357)

207.5 (983–298)

< 0.001